Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

BACKGROUND: In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as to whether hepatic arterial infusion chemotherapy (HAIC) or sorafenib is superior. We performed a prospective, open-label, non-comparative phase II study to assess survival with HAIC or HAIC converted to sor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatooka, Masahiro, Kawaoka, Tomokazu, Aikata, Hiroshi, Inagaki, Yuki, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Kawakami, Yoshiiku, Awai, Kazuo, Masaki, Keiichi, Waki, Koji, Kohno, Hirotaka, Kohno, Hiroshi, Moriya, Takashi, Nagaoki, Yuko, Tamura, Toru, Amano, Hajime, Katamura, Yoshio, Chayama, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987491/
https://www.ncbi.nlm.nih.gov/pubmed/29866075
http://dx.doi.org/10.1186/s12885-018-4519-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987491/
https://www.ncbi.nlm.nih.gov/pubmed/29866075
http://dx.doi.org/10.1186/s12885-018-4519-y

Ejemplares similares